PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAlbumin human
Albumin human
Optison (albumin human) is a protein pharmaceutical. Albumin human was first approved as Optison on 1997-12-31.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Albuked, plasbumin, plasbumin, plasbumin, Albuminex, Alburx, Albutein, Buminate, flexbumin, Human albumin grifols, Idelvion, Kedbumin, N/a, Optison (discontinued: Albuminar, albuminar, albuminar, albuminar, Albutein, Chromalbin, Human albumin grifols)
Combinations
Advate, Xyntha, xyntha solofuse
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Albumin human
Tradename
Company
Number
Date
Products
OPTISONGE HealthcareN-020899 RX1997-12-31
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
albumin (human)Biologic Licensing Application2010-01-07
albumin (human) 20%Biologic Licensing Application2009-12-16
albumin (human) 25%Biologic Licensing Application2009-12-22
albuminexBiologic Licensing Application2024-12-31
alburxBiologic Licensing Application2009-01-06
albuteinBiologic Licensing Application2008-07-01
beizray beizrayNew Drug Application2025-09-16
draximage maaBiologic Licensing Application2024-02-13
flexbuminBiologic Licensing Application2007-06-15
human albumin grifolsBiologic Licensing Application2010-09-08
Show 9 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
ALBUMIN HUMAN, OPTISON, GE HEALTHCARE
2028-05-09NPP
2028-05-09NPP
2028-05-09NPP
2028-05-09NPP
2028-05-09NPP
2028-05-09NPP
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
2855 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hemophilia aD006467EFO_0007267D66235——7
Hemophilia bD002836—D67235——7
Graft vs host diseaseD006086—D89.81—12——2
PolyneuropathiesD011115EFO_0009562A69.22——1——1
Chronic inflammatory demyelinating polyradiculoneuropathyD020277EFO_1000868G61.81——1——1
PolyradiculoneuropathyD011129EFO_1001116———1——1
AfibrinogenemiaD000347—D68.2—11——1
DermatomyositisD003882EFO_0000398M33——1——1
Atrial fibrillationD001281EFO_0000275I48.0——1——1
Heart failureD006333EFO_0003144I50——1——1
Show 14 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diffuse sclerodermaD045743EFO_0000404——1——12
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Factor vii deficiencyD005168—D68.21————1
Healthy volunteers/patients———1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Systemic sclerodermaD012595EFO_0000717M34————11
SclerosisD012598——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAlbumin human
INNperflutren
Description
Albuked (albumin human) is a protein pharmaceutical. It is currently being investigated in clinical studies.
Classification
Protein
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID200-941-9
RxCUI—
ChEMBL IDCHEMBL1201451
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDCK0N3WH0SR (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Human albumin grifols – Takeda
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Advate – Takeda
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 750,343 documents
View more details
Safety
Black-box Warning
Black-box warning for: Beizray beizray, Optison, Paclitaxel, Paclitaxel protein bound particles albumin bound, Paclitaxel protein-bound particles for injectable suspension (albumin-bound), Sterile diluent for allergenic extract
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4,696 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use